Evaluating the effect of measles and rubella mass vaccination campaigns on seroprevalence in India: a before-and-after cross-sectional household serosurvey in four districts, 2018-2020
- Murhekar, Manoj V
- Gupta, Nivedita
- Hasan, Alvira Z
- Kumar, Muthusamy Santhosh
- Kumar, V Saravana
- Prosperi, Christine
- Sapkal, Gajanan N
- Thangaraj, Jeromie Wesley Vivian
- Kaduskar, Ojas
- Bhatt, Vaishali
- Deshpande, Gururaj Rao
- Thankappan, Ullas Padinjaremattathil
- Bansal, Avi Kumar
- Chauhan, Sanjay L
- Grover, Gangandeep Singh
- Jain, Arun Kumar
- Kulkarni, Ragini N
- Sharma, Santanu Kumar
- Chaaithanya, Itta K
- Kharwal, Sanchit
- Mishra, Sunil K
- Salvi, Neha R
- Sharma, Sandeep
- Sarmah, Nilanju P
- Sabarinathan, R
- Duraiswamy, Augustine
- Rani, D Sudha
- Kanagasabai, K
- Lachyan, Abhishek
- Gawali, Poonam
- Kapoor, Mitali
- Shrivastava, Arpit Kumar
- Chonker, Saurabh Kumar
- Tilekar, Bipin
- Tandale, Babasaheb V
- Ahmad, Mohammad
- Sangal, Lucky
- Winter, Amy
- Mehendale, Sanjay M
- Moss, William J
- Hayford, Kyla
DOIAbstract
BACKGROUND: India did phased measles-rubella supplementary immunisation activities (MR-SIAs; ie, mass-immunisation campaigns) targeting children aged 9 months to less than 15 years. We estimated measles-rubella seroprevalence before and after the MR-SIAs to quantify the effect on population immunity and identify remaining immunity gaps. METHODS: Between March 9, 2018 and March 19, 2020 we did community-based, cross-sectional serosurveys in four districts in India before and after MR-SIAs. 30 villages or wards were selected within each district, and one census enumeration block from each was selected as the survey cluster. Households were enumerated and 13 children in the younger age group (9 months to <5 years) and 13 children in the older ...
Add to ORKG